HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.

AuthorsMaki Takabayashi, Rika Sakai, Heiwa Kanamori, Yoshiaki Ishigatsubo
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 44 Issue 5 Pg. 891-2 (May 2003) ISSN: 1042-8194 [Print] United States
PMID12802934 (Publication Type: Case Reports, Letter)
Chemical References
  • Cytarabine
Topics
  • Acute Disease
  • Cytarabine (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes (complications, drug therapy)
  • Primary Myelofibrosis (complications, drug therapy)
  • Remission Induction (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: